Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of Alopecia Areata With Tofacitinib.

Literature DB >> 28355451

Treatment of Alopecia Areata With Tofacitinib.

Omer Ibrahim¹, Cheryl B Bayart¹, Sara Hogan¹, Melissa Piliang¹, Wilma F Bergfeld¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2017 PMID： 28355451 PMCID： PMC5817614 DOI： 10.1001/jamadermatol.2017.0001

Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282

× No keyword cloud information.

5 in total

1. Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation.

Authors: Elise A Olsen; Maria K Hordinsky; Vera H Price; Janet L Roberts; Jerry Shapiro; Doug Canfield; Madeleine Duvic; Lloyd E King; Amy J McMichael; Valerie A Randall; Maria L Turner; Leonard Sperling; David A Whiting; David Norris
Journal: J Am Acad Dermatol Date: 2004-09 Impact factor: 11.527

2. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.

Authors: Luzhou Xing; Zhenpeng Dai; Ali Jabbari; Jane E Cerise; Claire A Higgins; Weijuan Gong; Annemieke de Jong; Sivan Harel; Gina M DeStefano; Lisa Rothman; Pallavi Singh; Lynn Petukhova; Julian Mackay-Wiggan; Angela M Christiano; Raphael Clynes
Journal: Nat Med Date: 2014-08-17 Impact factor: 53.440

3. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.

Authors: Milène Kennedy Crispin; Justin M Ko; Brittany G Craiglow; Shufeng Li; Gautam Shankar; Jennifer R Urban; James C Chen; Jane E Cerise; Ali Jabbari; Mårten Cg Winge; M Peter Marinkovich; Angela M Christiano; Anthony E Oro; Brett A King
Journal: JCI Insight Date: 2016-09-22

4. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.

Authors: Julian Mackay-Wiggan; Ali Jabbari; Nhan Nguyen; Jane E Cerise; Charlotte Clark; Grace Ulerio; Megan Furniss; Roger Vaughan; Angela M Christiano; Raphael Clynes
Journal: JCI Insight Date: 2016-09-22

5. Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.

Authors: Ali Jabbari; Nhan Nguyen; Jane E Cerise; Grace Ulerio; Annemieke de Jong; Raphael Clynes; Angela M Christiano; Julian Mackay-Wiggan
Journal: Exp Dermatol Date: 2016-08 Impact factor: 3.960

5 in total

17 in total

1. What is new in dermatotherapy?

Authors: Anupam Das; Anand Toshniwal; Bhushan Madke
Journal: Indian J Dermatol Venereol Leprol Date: 2021 Jan-Feb Impact factor: 2.545

2. Factors associated with insurance coverage of tofacitinib for alopecia areata: A retrospective review from an academic institution.

Authors: Hannah J Thompson; Theresa Vavra; Ali Jabbari
Journal: J Am Acad Dermatol Date: 2020-06-14 Impact factor: 11.527

Review 3. JAK Inhibitors for Treatment of Alopecia Areata.

Authors: Eddy H C Wang; Brigitte N Sallee; Christina I Tejeda; Angela M Christiano
Journal: J Invest Dermatol Date: 2018-07-26 Impact factor: 8.551

Review 4. [Janus kinase inhibitors for the treatment of alopecia areata].

Authors: Inbar Kobal; Yuval Ramot
Journal: Hautarzt Date: 2022-04-28 Impact factor: 0.751

5. Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study.

Authors: Wenxin Zhang; Xiangqian Li; Baifu Chen; Jianzhong Zhang; Kara Melissa T Torres-Culala; Cheng Zhou
Journal: Front Med (Lausanne) Date: 2022-06-21

Treatment of Alopecia Areata With Tofacitinib.

1. Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation.

2. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.

3. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.

4. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.

5. Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.

1. What is new in dermatotherapy?

2. Factors associated with insurance coverage of tofacitinib for alopecia areata: A retrospective review from an academic institution.

Review 3. JAK Inhibitors for Treatment of Alopecia Areata.

Review 4. [Janus kinase inhibitors for the treatment of alopecia areata].

5. Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study.

Review 6. The current state of knowledge of the immune ecosystem in alopecia areata.

7. High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.

Review 8. New and Emerging Therapies for Alopecia Areata.

Review 9. Local heroes or villains: tissue-resident memory T cells in human health and disease.

10. Effectiveness of Oral Tofacitinib Dose Tapering in a Case of Alopecia Areata Universalis.